Studies Toward the Asymmetric Synthesis of Novel Chiral 1,4-Oxazepan Derivatives

dc.contributor.advisor Çağır, Ali
dc.contributor.author Vural, Ezgi
dc.date.accessioned 2021-08-16T11:51:25Z
dc.date.available 2021-08-16T11:51:25Z
dc.date.issued 2020
dc.description Includes bibliographical references (leaves. 52-56) en_US
dc.description Text in English; Abstract: Turkish and English en_US
dc.description Thesis (Master)--Izmir Institute of Technology, Chemistry, Izmir, 2020 en_US
dc.description.abstract Pharmacophore design to inhibit the interaction between p53 and MDM2 became a novel approach for cancer therapy. p53, known as the guardian of genome, controls the cell cycle arrest, apoptosis and DNA repair under stress. Nonetheless, when over-expressed, MDM2 causes proliferation in the cell and eventually tumorgenesis. The feedback mechanism between p53 and MDM2 arises from the interaction of p53 through the hydrophobic cleft which consists of Phe19, Trp23 and Leu26 aminoacids in the N-terminal of MDM2. In this study, it was aimed to synthesize a new, chiral 1,4-oxazepan-5-one derivatives by asymmetric synthesis. (R)-2-amino-2-(4-chlorophenyl)acetic acid was used as starting material. Amino group was protected by trityl group then the carboxylic acid part was reduced by LiAlH4 to produce N-trityl-protected amino alcohol. Dess Martin periodinane was used for the oxidation of the alcohol to the aldehyde, then 3-chlorophenylmagnesium bromide was added to the aldehyde by Grignard reaction. Deprotection of N-trityl was performed with TFA then, coupling reactions of produced aminoalcohol with different α,β-unsaturated carboxylic acids were performed by HATU and DIPEA. Despite all of the attempts, cyclization to seven membered 1,4-oxazepan-5-one ring was never achieved. en_US
dc.description.abstract p53 ve MDM2 arasındaki etkileşimi engellemek için farmakofor tasarımı kanser terapisinde yeni bir yaklaşım olmaktadır. Genomum koruyucusu olarak bilinen p53 stres altında hücre siklusunda aresti, apaptozu ve DNA tamirini kontrol eder. Bununla birlikte, MDM2 fazla eksprese edildiğinde hücrenin çabuk çoğalmasına ve neticede tümör oluşumuna neden olur. p53 ve MDM2 arasındaki geribesleme mekanizması p53'ün, MDM2'nin N-ucundaki Phe19, Trp23 ve Leu26 aminoasitlerinden oluşan hidrofobik boşluktan etkileşir. Bu çalışmada asimetrik sentez ile yeni kiral 1,4-oksazepan-5-on türevlerinin sentezlenmesi amaçlanmıştır. (R)-2-amino-2-(4-chlorophenyl)acetik asit başlangıç maddesi olarak kullanıldı. Amino grubu tritil grubu ile korundu ve daha sonra maddenin karboksilik asit kısmı LiAlH4 ile N-korunmalı amino alkol elde edmek üzere indirgendi. Dess Martin periodinane alkolün aldehite oksidasyon için kullanıldı, daha sonra 3-klorofenilmagnezyum bromür Grignard reaksiyonu ile aldehite eklendi. Koruyucu tritil grubu TFA ile uzaklaştırıldı ve oluşan aminoalkolün farklı α,β-doymamış karboksilik asit ile bağlanma reaksiyonları HATU ve DIPEA kullanılarak gerçekleştirildi. Tüm denemelere rağmen yedi üyeli 1,4-oksazepan-5-on halkalaşması hiç bir zaman gerçekleştirilemedi. en_US
dc.format.extent xiii, 56 leaves
dc.identifier.citation Vural, E. (2020). Studies toward the asymmetric synthesis of novel chiral 1,4-oxazepan-5-one derivatives. Unpublished master's thesis, İzmir Institute of Technology, İzmir, Turkey en_US
dc.identifier.uri https://hdl.handle.net/11147/11077
dc.language.iso en en_US
dc.publisher 01. Izmir Institute of Technology en_US
dc.relation Potansiyel MDM2-P53 ve Aromataz Enzim İnhibitörleri Olabilecek 1,2,4-Triazol Türevlendirilmiş 1,4-Oksazepin-5-On Moleküllerinin Sentezi en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Asymmetric synthesis en_US
dc.subject Pharmacophore en_US
dc.subject p53-MDM2 interaction en_US
dc.subject Cancer drugs en_US
dc.subject Drug discovery en_US
dc.title Studies Toward the Asymmetric Synthesis of Novel Chiral 1,4-Oxazepan Derivatives en_US
dc.title.alternative Yeni Kiral 1,4-okzazepan-5-on Türevlerinin Asimetrik Sentezine Yönelik Çalışmalar en_US
dc.type Master Thesis en_US
dspace.entity.type Publication
gdc.author.id 0000-0002-7350-3747
gdc.author.id 0000-0002-7350-3747 en_US
gdc.coar.access open access
gdc.coar.type text::thesis::master thesis
gdc.contributor.affiliation 01. Izmir Institute of Technology en_US
gdc.description.department Thesis (Master)--İzmir Institute of Technology, Chemistry en_US
gdc.description.scopusquality N/A
gdc.description.wosquality N/A
relation.isAuthorOfPublication.latestForDiscovery 33faaa20-5395-4b1e-b56c-ae2eef4ff1e8
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4003-8abe-a4dfe192da5e

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Name:
10176151.pdf
Size:
1.43 MB
Format:
Adobe Portable Document Format
Description:
MasterThesis

License bundle

Now showing 1 - 1 of 1
Loading...
Name:
license.txt
Size:
3.2 KB
Format:
Item-specific license agreed upon to submission
Description: